Millennium Management
CTNM

Millennium Management’s Contineum Therapeutics CTNM Stock Holding History

Millennium Management’s Portfolio CTNM Stock Details CTNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$20.1M Buy
1,535,449
+704,762
+85% +$9.45M 0.01% 1551
2025
Q4 		$9.49M Buy
830,687
+184,665
+29% +$2.11M ﹤0.01% 2323
2025
Q3 		$7.59M Buy
646,022
+513,644
+388% +$4.14M ﹤0.01% 2684
2025
Q2 		$526K Buy
+132,378
New +$575K ﹤0.01% 4878

Other funds holding CTNM

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Millennium Management's CTNM Position: Q1 2026 in Review

Millennium Management increased its Contineum Therapeutics (CTNM) stake by 85% in Q1 2026, buying an estimated $9.45M and bringing the position to 1,535,449 shares worth $20.1M. The position accounts for 0.01% of the portfolio, ranked #1551.

Millennium Management first reported a position in CTNM in Q2 2025 and has held it in 4 quarters since. 90 funds tracked by Wall St. Rank hold CTNM as of Q1 2026.

  • Millennium Management held 1,535,449 shares of Contineum Therapeutics worth $20.1M as of Q1 2026.
  • Millennium Management bought 704,762 Contineum Therapeutics shares in Q1 2026, an estimated $9.45M.
  • Contineum Therapeutics made up 0.01% of Millennium Management's portfolio in Q1 2026, its #1551 holding.
  • Millennium Management first reported a position in Contineum Therapeutics in Q2 2025 and has held it in 4 quarters since.
  • 90 funds tracked by Wall St. Rank held Contineum Therapeutics as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.